• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1500043 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-08-12 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd;Medimmune LLC Certificate Issued 2016-08-25 view
JXSL1700054 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2017-09-13 MedImmune LLC Medimmune LLC Certificate Issued 2018-01-23 view
JXSL2200045 Tremelimumab tremelimumab Injection Biological Products(1) Import Drug Application 2022-04-12 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL1500071 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-12-11 MedImmune LLC Medimmune LLC Certificate Issued 2016-11-08 view
JXSB2000021 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2020-09-23 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2020-09-22 view
JXSL1700027 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2017-05-31 MedImmune LLC Medimmune LLC Certificate Issued 2017-10-27 view
JXSL2200021 Tremelimumab tremelimumab Injection Biological Products(1) Import Drug Application 2022-03-04 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL1500067 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-11-26 MedImmune LLC Medimmune LLC Certificate Issued 2017-01-03 view
JYSB1900344 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2019-12-18 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2019-12-17 view
JXSL2500005 Tremelimumab tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-01-09 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view
JXSL1700013 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2017-03-27 MedImmune LLC Medimmune LLC Certificate Issued 2017-08-22 view
JXSB2101101 Tremelimumab tremelimumab Injection Biological Products(1) Supplementary Application 2021-12-07 Vetter Pharma-Fertigung Gmbh & Co KG;Medimmune LLC view
JXSL1500065 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-11-26 MedImmune LLC Medimmune LLC Certificate Issued 2016-08-25 view
JXSL1800076 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2019-01-09 Medimmune LLC In Review 2019-01-08 view
JXSB2300114 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2023-09-23 Vetter Pharma-Fertigung Gmbh & Co KG;Medimmune LLC view
JXSB2100010 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2021-02-06 Medimmune LLC;Boehringer Ingelheim Pharma Gmbh & Co KG In Review 2021-02-05 view
JXSL1500063 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2015-11-26 MedImmune LLC Medimmune LLC Certificate Issued 2016-09-29 view
JXSL1800046 Tremelimumab tremelimumab Injection Biological Products Import Drug Application 2018-11-09 Medimmune LLC In Review 2018-11-08 view
JXSB2300115 Tremelimumab tremelimumab Injection Biological Products Supplementary Application 2023-09-23 Vetter Pharma-Fertigung Gmbh & Co KG;Medimmune LLC view
JXSL2500004 Tremelimumab tremelimumab Injection Biological Products(2.2) Import Drug Application 2025-01-09 Medimmune LLC;AstraZeneca Global R&D (China) Co Ltd view